title: Primary gastric lymphoma.
abstract: The records of 30 patients with primary gastric lymphoma and a minimum of 5 years of follow-up were reviewed and clinical and pathologic prognostic factors analyzed. The overall 5-year survival was 40% (median 23 months). No significant relationship between surgical and patient age, sex, duration of symptoms, macroscopic appearance, or size of the primary lesion or degree of serosal infiltration was demonstrated. Stage of disease and site of primary had an impact on prognosis. Survival was improved in patients with stage I-II disease (P < 0.05) and in patients with primary located in the distal third of the stomach (P < 0.05). Although histology in all three classifications did not correlate well with survival, patients with low-grade lymphoma according to Kiel showed improved outcome (P < 0.05). Five-year survival of 11 patients with positive lymph nodes, 6 of whom were treated with cytotoxic therapy, was 54% and comparable to that of 7 patients (56%) with no nodal involvement who did not receive chemotherapy after surgery.
authors.affiliation: Institute of Special Surgical Pathology, University of Genoa, Italy.
authors.forename: G B
authors.initials: GB
authors.lastname: Secco
authors.forename: R
authors.initials: R
authors.lastname: Fardelli
authors.forename: E
authors.initials: E
authors.lastname: Campora
authors.forename: F
authors.initials: F
authors.lastname: Munizzi
authors.forename: H
authors.initials: H
authors.lastname: Aste
authors.forename: G
authors.initials: G
authors.lastname: Nicolò
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013274:Stomach Neoplasms / Q000473:pathology / Q000628:therapy; D016019:Survival Analysis; D016896:Treatment Outcome